Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lidi
- Ownership
- Private
- Development stage
- Other
01
Overview
Lidi is a biotechnology company focused on the discovery and development of novel therapeutic agents, primarily targeting oncology and metabolic diseases. The company leverages its expertise in medicinal chemistry and molecular biology to identify and optimize small molecule candidates. Lidi aims to address significant unmet medical needs through innovative drug design and rigorous preclinical evaluation. Its current pipeline is in the early stages of development, with several programs undergoing lead optimization and characterization.
- Therapeutic areas
- OncologyMetabolic Disorders
- Modalities
- Small molecule
- Industry
- Biotech
Beyond the preview
Go deeper on Lidi.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lidi.